Biocartis Group, 4% 9nov2027, EUR (Conv.) (FIGI BBG00P2C3PR7, BE0002651322, WKN A2R1YZ)
国内債券, 転換社債, Senior Unsecured
国内債券, 転換社債, Senior Unsecured
|
Biocartis Group NV, a molecular diagnostics company, provides diagnostic solutions enhancing clinical practice for the benefit of patients, clinicians, payers, and healthcare industry, with a focus on oncology.
|
|
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
167 970
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡